H. Lundbeck AS (OCSE:HLUN A)
kr 35.7 -0.1 (-0.28%) Market Cap: 41.36 Bil Enterprise Value: 39.36 Bil PE Ratio: 13.68 PB Ratio: 1.53 GF Score: 44/100

Q2 2024 H Lundbeck A/S Earnings Call Transcript

Aug 21, 2024 / 11:00AM GMT
Release Date Price: kr40 (+3.90%)

Key Points

Positve
  • H. Lundbeck AS (HLUBF) reported a strong first half of 2024 with a 10% increase in total top-line revenue.
  • Strategic brands, including Vyepti and Rexulti, showed significant growth, with Vyepti achieving a 78% year-over-year increase in global net revenues.
  • The company raised its financial guidance for 2024, reflecting confidence in its strategic direction and performance.
  • H. Lundbeck AS (HLUBF) is advancing its R&D pipeline, with promising developments in areas such as PTSD and neuro-rare assets.
  • The company has successfully reallocated resources to focus on high-growth areas, enhancing its strategic brand investments and optimizing its commercial strategy.
Negative
  • The adjusted gross margin decreased by 1.3 percentage points due to higher raw material and manufacturing costs.
  • Sales and distribution costs increased by 10%, reflecting continued investments in strategic assets, which may impact short-term profitability.
  • Administrative expenses rose by 31%, driven by higher legal and personnel costs, which could affect overall financial performance.
  • The adjusted EBITDA margin decreased by 2.1 percentage points, influenced by higher costs and unfavorable currency effects.
  • There are concerns about potential generic competition for Abilify Maintena in the US and EU, which could impact future revenue.
Charl Van Zyl;S;President
H Lundbeck A;Chief Executive Officer

/- -

Welcome, and thank you for joining us today on our earnings call. It's, of course, my pleasure to be with you and be able to express my confidence around our first half results. Our goal today is, of course, to give you a comprehensive update. And we look forward to, of course, your questions and engaging with you on the full first half results for 2024.

If you can go to the next slide, please. Of course, today will contain some statements, and these are forward-looking statements and are subject to change.

If we can go to the next slide. And please, of course, the agenda here today is my pleasure to rejoin, of course, with my management team. You will hear from our two Executive Vice Presidents for our geographic operations: Tom Gibbs, for the US.; and Michala Fischer-Hansen for Europe and international markets. You will also hear from Johan Luthman, who is our Head of Research and Development; and of course, also our CFO, Joerg Hornstein, around full financial update.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot